Technical Analysis for PRTK - Paratek Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade A 6.69 2.45% 0.16
PRTK closed up 2.45 percent on Friday, September 18, 2020, on 2.29 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical PRTK trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish 2.45%
Expansion Breakout Bullish Swing Setup 2.45%
Older End-of-Day Gignals for PRTK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Paratek Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of antibiotics to save lives and alleviate suffering. It offers, omadacycline, a tetracycline-derived, broad-spectrum antibiotic for use as a first-line monotherapy for acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, urinary tract infections, and other serious community-acquired bacterial infections. The company also provides WC 3035, a tetracycline-derived compound with dual narrow-spectrum antibacterial and potent anti-inflammatory activity for use in the treatment of acne and rosacea. In addition, it offers solutions for multiple sclerosis, SMS, and RA/IBD. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.
Medicine Biopharmaceutical Clinical Medicine Organ Systems Infection Multiple Sclerosis SMS Antibiotics Hepatotoxins Acne Antibiotic Skin And Skin Structure Infections Urinary Tract Infections Community Acquired Bacterial Pneumonia Ibd Omadacycline Rosacea

Is PRTK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.72
52 Week Low 2.5
Average Volume 679,094
200-Day Moving Average 4.23
50-Day Moving Average 4.78
20-Day Moving Average 5.08
10-Day Moving Average 5.51
Average True Range 0.43
ADX 38.21
+DI 37.72
-DI 7.91
Chandelier Exit (Long, 3 ATRs ) 5.44
Chandelier Exit (Short, 3 ATRs ) 5.42
Upper Bollinger Band 6.53
Lower Bollinger Band 3.63
Percent B (%b) 1.05
BandWidth 57.00
MACD Line 0.44
MACD Signal Line 0.23
MACD Histogram 0.2116
Fundamentals Value
Market Cap 185.72 Million
Num Shares 27.8 Million
EPS -3.95
Price-to-Earnings (P/E) Ratio -1.69
Price-to-Sales 77.65
Price-to-Book 5.15
PEG Ratio -0.02
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.46
Resistance 3 (R3) 7.38 7.05 7.33
Resistance 2 (R2) 7.05 6.86 7.09 7.28
Resistance 1 (R1) 6.87 6.73 6.96 6.95 7.24
Pivot Point 6.54 6.54 6.59 6.58 6.54
Support 1 (S1) 6.36 6.35 6.45 6.44 6.14
Support 2 (S2) 6.03 6.22 6.07 6.10
Support 3 (S3) 5.85 6.03 6.05
Support 4 (S4) 5.93